Effect of supplementation in treatment of gestational diabetes

Phase 2

• Conditions: Gestational diabetes.; Diabetes mellitus in pregnancy, unspecified; O24.9

• Registration Number: IRCT201407115623N23
• Lead Sponsor: Arak University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 October 2019

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

Pregnant women aged 18-40 years; diagnosed with GDM at 24-28 weeks' gestation

Exclusion Criteria

Multiple gestation,
Major fetal anomalies
Current illicit drug use
Continuous daily Ca and/or vitamin D intake since last menstrual period
Insulin-dependent diabetes
Smoking
History of kidney stones

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ewborn's weight. Timepoint: Delivery time. Method of measurement: Scale.

Secondary Outcome Measures

Name	Time	Method
ewborn's head circumference. Timepoint: Delivery time. Method of measurement: Tape.;Ponderal index. Timepoint: Delivery time. Method of measurement: Calculation.;Polyhydramnios. Timepoint: End-of-trial. Method of measurement: Sonographic.;Newborn's length. Timepoint: Delivery time. Method of measurement: Tape.;Newborn's bilirubin. Timepoint: Delivery time. Method of measurement: Enzymatic kit.;Apgar score. Timepoint: Delivery time. Method of measurement: Clinical observation.;Newborns' hypoglycemia. Timepoint: After delivery. Method of measurement: Enzymatic kit.;Preterm delivery. Timepoint: After delivery. Method of measurement: Medical record.;Maternal pre-eclampsia. Timepoint: After delivery. Method of measurement: Medical record.;Maternal hospitalization. Timepoint: After delivery. Method of measurement: Medical record.;Newborns' hospitalization. Timepoint: After delivery. Method of measurement: Medical record.